Results 81 to 90 of about 2,733 (199)

Dynamic Cap‐Mediated Substrate Access and Potent Inhibitor Design of Monkeypox Virus I7L Protease

open access: yesAdvanced Science, Volume 12, Issue 26, July 10, 2025.
The first crystal structure of MPXV I7L protease, revealing its unique dimeric form is resolved. The structures and MD simulations uncovered a dynamic cap region that regulates substrate access to the active site. The structural basis of substrate recognition and the catalytic mechanism are elucidated, which led to the development of a FRET‐based assay
Haixia Su   +12 more
wiley   +1 more source

The Human Mpox Global Outbreak: Available Control Tools and the Opportunity to Break a Cycle of Neglect in Endemic Countries [PDF]

open access: yes, 2023
The 2022 global outbreak of human Mpox (formerly monkeypox) virus (MPXV) infection outside of the usual endemic zones in Africa challenged our understanding of the virus’s natural history, transmission dynamics, and risk factors.
Andrei, G   +16 more
core  

Low Specific T‐Cell Immunity Against Mpox Elicited in People With HIV‐1 and PrEP Users After Subcutaneous Vaccination Compared to Natural Infection

open access: yesJournal of Medical Virology, Volume 97, Issue 7, July 2025.
ABSTRACT In August 2024, the World Health Organization declared mpox infection a Public Health Emergency of International Concern for second time since 2022 and recommended vaccinating all people at‐risk, such as people with HIV‐1 (PWH) and prophylaxis pre‐exposition (PrEP) users.
Olivia de la Calle‐Jiménez   +16 more
wiley   +1 more source

Interdisciplinary Approach to Monkeypox Prevention: Integrating Nanobiosensors, Nanovaccines, Artificial Intelligence, Visual Arts, and Social Sciences

open access: yesSmall Structures, Volume 6, Issue 7, July 2025.
This illustration depicts a comprehensive strategy against monkeypox, showcasing its transmission, symptoms, and prevention. Centralized around nanomaterials and biosensors, it integrates early screening, Internet of Things, vaccination, and community involvement through collaboration among healthcare workers, scientists, researchers, social groups ...
Vishal Chaudhary   +3 more
wiley   +1 more source

Tecovirimat in the management of poxviruses: a narrative review of available evidence

open access: yesThe Egyptian Journal of Internal Medicine
Introduction Tecovirimat (TPOXX) is an effective antiviral medication recommended for treating smallpox and other Orthopoxvirus infections. With the rise in monkeypox (mpox) cases globally, there is an urgent need to explore therapeutic options to manage
Olalekan John Okesanya   +13 more
doaj   +1 more source

Interim guidance for prevention and treatment of monkeypox in persons with HIV infection \u2014 United States, August 2022 [PDF]

open access: yes
What is already known about this topic? A multinational monkeypox outbreak disproportionately affecting men who have sex with men, including persons with HIV infection, is ongoing worldwide.What is added by this report?

core  

Clinical considerations for mpox in people who are pregnant or breastfeeding [PDF]

open access: yes
Updated March 27, 2023Mpox and Pregnancy -- Signs and Symptoms -- Treatment -- Vaccines -- Contact and Breastfeeding -- Infection ...

core  

Challenges in clinical diagnosis of Clade I Mpox: Highlighting the need for enhanced diagnostic approaches [PDF]

open access: yes
Background: Due to limited diagnostic capacity and availability of point-of-care tests, diagnosis of Clade I mpox in the geographical regions most affected is usually on clinical grounds.
Boum, Yap   +8 more
core   +2 more sources

News and Views [PDF]

open access: yes, 2022
Around The ...
ijcp group
core   +1 more source

Tecovirimat for monkeypox

open access: yesCanadian Medical Association Journal, 2022
Halani, Sheliza   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy